Lysophospholipids as Biomarkers of Ovarian Cancer
A method of using a bioactive lysophospholipid (LL) as a biomarker for detecting the presence and recurrence of ovarian cancer. Subspecies of LL, such as lysophosphatidic acid (LPA), lysophosphatidylinositol (LPI), lysophosphatidylcholine (LPC), and lysosphingolipid sphinsosine-1-phosphate (S1P), are used alone or in conjunction to increase the specificity and sensitivity of the assay.
US 7,964,408 issued 2011-07-21 [MORE INFO
SUTPHEN REBECCA [US]
Type of Offer:
« More Biotech Patents